EXCLUSIVE: JPMorgan cuts ties with OxyContin maker Purdue Pharma
- JPMorgan Chase & Co has cut ties with Purdue Pharma LP over the OxyContin maker’s alleged role in the U.S. opioid crisis, forcing it to find a new bank to manage cash and bill payments, people familiar with the matter said on Thursday.
JPMorgan’s decision also underscores a drive among U.S. banks to reassess their relationships with clients and industries in response to controversy and political debates over matters such as immigration detention and mass shootings. While not a lender to Purdue, JPMorgan’s commercial bank managed the company’s cash and bill payments, according to the sources. It is not clear how long JPMorgan served as Purdue’s bank.
Purdue denies it contributed to the U.S. opioid crisis, pointing to U.S. Food and Drug Administration approvals of labels for the company’s drugs that carried warnings about risk and abuse associated with treating pain. Purdue and its family owners argue that heroin and fentanyl are currently more significant culprits in the opioid epidemic.
In New York, The Metropolitan Museum of Art, which has a wing named for the Sacklers, and the American Museum of Natural History, said earlier this month they had ceased accepting donations from the family.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Five more U.S. states sue OxyContin maker Purdue Pharma over opioid epidemicIowa, Kansas, Maryland, West Virginia and Wisconsin joined 39 states to file lawsuits targeting Purdue Pharma and its leaders, including former president Richard Sackler and his family. Officials accused Purdue Pharma of repeatedly making false and deceptive claims that opioids, including OxyContin,
Weiterlesen »
Five more U.S. states sue OxyContin maker Purdue Pharma over opioid epidemicFive U.S. states on Thursday filed lawsuits accusing Purdue Pharma LP of illegal...
Weiterlesen »
Five more states sue OxyContin maker Purdue Pharma for opioid epidemicFour of the states — Iowa, Maryland, Wisconsin and West Virginia — also sued the company's former president Richard Sackler.
Weiterlesen »
Purdue Pharma Hit With Fresh Round of Opioid LawsuitsSix more states launched legal actions this week against Purdue Pharma alleging the company misled the public and medical communities about the addictive risks of its OxyContin prescription painkiller.
Weiterlesen »
Congressional report: Purdue Pharma influenced World Health Organization’s opioid guidelinesA bipartisan investigation alleges the international group took directions from the drugmaker’s marketing and sales strategies.
Weiterlesen »
U.N. agency is accused of helping Purdue Pharma make opioid epidemic globalTwo members of Congress accused the World Health Organization of helping Purdue Pharma use the same “propaganda campaign” that fueled the opioid epidemic in the U.S. to expand drug sales internationally.
Weiterlesen »
Exclusive: Banks to invest around $50 million in digital cash settlement project - sourcesSeveral of the world's largest banks are in the process of investing around...
Weiterlesen »
Exclusive: FBI targets Johnson & Johnson, Siemens, GE, Philips in Brazil graft case - sourcesThe FBI is investigating corporate giants Johnson & Johnson, Siemens, General El...
Weiterlesen »
Exclusive: Tencent and Riot Games developing mobile version of League of Legends -sourcesChina's Tencent Holdings Ltd is working with its U.S. unit Riot Games to de...
Weiterlesen »
Exclusive: Google suspends some business with Huawei after Trump blacklist - sourceExclusive: Google suspends some business with Huawei after Trump blacklist, sources tell angelamoon00
Weiterlesen »
Exclusive: India watchdog probes allegations of anti-competitive conduct by Maruti - sourcesEXCLUSIVE: India's antitrust regulator is looking into allegations that Maruti Suzuki, the country's biggest car maker, resorted to anti-competitive practices by controlling how its dealers discounted cars by AditiShahsays AdityaKalra
Weiterlesen »